VCEL FY 2019 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$118M+29.7% YoY

Gross Profit

$80M68.1% margin

Operating Income

-$11M-9.5% margin

Net Income

-$10M-8.2% margin

EPS (Diluted)

$-0.18

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$10M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$153M

Total Liabilities

$42M

Stockholders' Equity

$111M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$118M	$91M	+29.7%
Gross Profit	$80M	$59M	+36.8%
Operating Income	-$11M	-$4M	-187.8%
Net Income	-$10M	-$8M	-18.8%